CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)
Recruiting · NCT06119867 · Interventional (participants receive a specific treatment) · Lead sponsor: Russian Society of Colorectal Surgeons
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.
Who can take part
Inclusion criteria
- Patients diagnosed with colon cancer who underwent colectomy;
- Patients with pathological confirmed adenocarcinoma;
- Patients agreed to participate in the study.
Exclusion criteria
- Patients suffered from rectal cancer;
- Patients diagnosed with colon cancer but did not undergo colectomy;
- Patients refused participation.
Where it is running
1 location listed.
- Clinic of coloproctology and minimally invasive surgery - Moscow, Russia